Fibrinolytic Activator, Glutamic Oxaloacetic Transaminase and Potassium in Myocardial Tissue at Various Stages of Human Myocardial Infarction

Simon Fischer; Ole K. Albrechtsen; Nils U. Bang

doi:10.1055/s-0038-1654410

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1959; 3(04): 554-565
DOI: 10.1055/s-0038-1654410

Originalarbeiten — Original Articles — Travaux Originaux

Schattauer GmbH

Fibrinolytic Activator, Glutamic Oxaloacetic Transaminase and Potassium in Myocardial Tissue at Various Stages of Human Myocardial Infarction

Simon Fischer

¹The Institute of Pathology, Frederiksberg Hospital, Copenhagen, the Biological Institute of the Carlsberg Foundation, Copenhagen, and the Clinical Laboratory, Kommunehospitalet, Copenhagen, Denmark

,

Ole K. Albrechtsen

¹The Institute of Pathology, Frederiksberg Hospital, Copenhagen, the Biological Institute of the Carlsberg Foundation, Copenhagen, and the Clinical Laboratory, Kommunehospitalet, Copenhagen, Denmark

,

Nils U. Bang

¹The Institute of Pathology, Frederiksberg Hospital, Copenhagen, the Biological Institute of the Carlsberg Foundation, Copenhagen, and the Clinical Laboratory, Kommunehospitalet, Copenhagen, Denmark

› Author Affiliations

References
1 Albrechtsen O. K. The fibrinolytic activity of human tissues. Brit. J. Haematol 1957; 3: 284
2 Astrup T. Biological significance of fibrinolysis. Lancet 1956; 271: 565
3 Astrup T, Albrechtsen O. K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand. J. clin. Lab. Invest 1957; 9: 3
4 Bing R. J, Castellanos A, Gradel E, LuptOn C, Siegel A. Experimental myocardial infarction. Amer. J. med. Sci 1956; 232: 533
5 Blumgart H. L, Gilligan D. R, Schlesinger M. J. Experimental studies on the effect of temporary occlusion of coronary arteries. Amer. Heart J 1941; 22: 374
6 Henley K. S, Pollard H. M. A new method for the determination of glutamic-oxaloacetic transaminase and glutamic pyruvic transaminase in plasma. J. Lab. clin. Med 1955; 46: 785
7 Jennings R. B, Crout J. R, Smellers G. W. Studies on distribution and localization of potassium in early myocardial ischemic injury. Arch. Path. (Chicago) 1957; 63: 586
8 Jennings R. B, Kaltenbach J. P, Smetters G. W. Enzymatic changes in acute myocardial ischemic injury. Arch. Path. (Chicago) 1957; 64: 10
9 Karmen A. A note on the spectrophotometric assay of glutamic oxaloacetic transaminase activity in human serum. J. clin. Invest 1955; 34: 131
10 Kattus A. A, Watanabe R, Semenson C. Diagnostic and prognostic significance of serum transaminase levels in coronary occlusive disease. Circulation (N. Y.) 1957; 15: 502
11 Kent S. P. Effect of post mortem autolysis on certain histochemical reactions. Arch. Path. (Chicago) 1957; 64: 17
12 Lunseth J. H, Ruwalt M. Pathogenesis of cardiac rupture due to myocardial infarction. Dis. Chest 1956; 30: 499
13 Mallory G. K, White P. D, Salcedo S. J. The speed of healing of myocardial infarction. Amer. Heart J 1939; 18: 647
14 Nydick I, Wroblewski F, La Due J. S. Evidence for increased serum glutamic oxaloacetic transaminase. Circulation (N. Y.) 1955; 12: 161
15 Rodeck H. Der Kalium-Inhalt im kranken Muskel. Schweiz. med. Wschr 1953; 83: 1137
16 Siegel A, Bing R. J. Plasma enzyme activity in myocardial infarction in dog and man. Proc. Soc. exp. Biol. (N. Y.) 1956; 91: 604
17 Tennant R, Grayzel D. M, Sutherland F. A, Stringer S. W. Studies on experimental coronary occlusion. Chemical and anatomical changes in the myocardium after coronary ligation. Amer. Heart J 1936; 12: 168
18 Wallace W. M. The application of the internal standard flame photometer to the analysis of biological material. J. Lab. clin. Med 1951; 37: 621